Radiant Submits Safety Analysis to U.S. Department of Energy in Major Milestone for Start Up of First Reactor

The MarketWatch News Department was not involved in the creation of this content. Submission begins 45 day approval period, paving way for start up of first reactor at INL's DOME facility next year.
MPR

FDA Updates Safety Warnings, Restricts DMD Indication for Elevidys

The indication was restricted to only patients with DMD who are 4 years of age and older with a confirmed mutation in the DMD gene; the indication for non-ambulatory patients with DMD was removed.

Zymeworks Surges On Positive Ziihera Phase 3 Data: Expanding First-Line GEA Opportunity

Zymeworks surges on positive Phase 3 Ziihera data in HER2-positive cancer. Discover key catalysts and what’s next for ZYME ...

Entrada Therapeutics: Soft Q3 Earnings, But Builds Momentum Toward 2026 Readouts

Entrada Therapeutics reported a 3Q25 GAAP EPS loss of –$1.06 and revenue of $1.6 million, reflecting declining collaboration ...
Kauppalehti

High Dose Regimen of Nusinersen Receives Positive CHMP Opinion for the Treatment of Spinal Muscular Atrophy

Positive CHMP opinion is based on data from the DEVOTE study which evaluated the high dose regimen of nusinersen in treatment-naive participants and those transitioning from the currently approved ...